National Tay-Sachs & Allied Diseases Association

What National Tay-Sachs & Allied Diseases Association does

National Tay-Sachs & Allied Diseases Association (NTSAD) is a U.S. non-profit patient-advocacy and research-support organization founded in 1957 and headquartered in Boston, Massachusetts. Per the input data, it operates with a small staff of 1–10 employees and is led by a board chair (Blyth Lord) and a research director (Valerie Greger), with public web presence at ntsad.org. Its stated mission scope covers Tay-Sachs disease together with 'allied diseases,' explicitly including Canavan, GM1, and Sandhoff diseases — a cluster of rare lysosomal storage and neurodegenerative disorders.

NTSAD's functional role sits at the intersection of family support, patient advocacy, and research stewardship for a niche rare-disease community. Its core activities, as evidenced by leadership titles and organizational naming, include directing or curating research programs (via the Research Director function), convening affected families, and serving as an information/resource hub for the conditions within its scope. No commercial products, technology platforms, clinical pipelines, or revenue-generating services were disclosed in the input data, which is consistent with a traditional 501(c)(3)-style patient association model rather than a venture-backed or product-oriented entity.

As a non-profit, NTSAD's 'business model' is donations-, grants-, and event-based rather than transactional. No pricing model, customer contracts, sponsor relationships, fundraising totals, or financial disclosures were provided in the input, so monetization mechanics, donor mix, and operational scale cannot be quantified from the supplied evidence. The primary first-party data surface (ntsad.org) returned largely loading-page content, indicating thin observable signal beyond the basic organizational identity.

Name

National Tay-Sachs & Allied Diseases Association

Website

https://ntsad.org

Company type

Private

Founded year

1957

Headcount range

1–10 employees

Short description

National Tay-Sachs & Allied Diseases Association is a Boston-based non-profit founded in 1957 that supports patients and families affected by Tay-Sachs, Canavan, GM1, and Sandhoff diseases through advocacy and research stewardship.

Ownership category

akta.pro rank

Product category

Rare Disease Patient Advocacy

NAICS

Other Individual and Family Services (624190), Individual and Family Services (6241)

SIC

Services-Social Services (8300)

akta.pro primary industry

Disease-Specific Global Programs (HIV/TB/Malaria/NTDs) (HLAJAKAF)

akta.pro secondary industry

Non-Communicable Disease Prevention & Chronic Disease Programs (BPAIAJAI)

Keywords

• Rare disease advocacy
• Patient support services
• Genetic disease research
• Family support programs
• Disease awareness education

Headquarters

HQ city

Boston

HQ country

United States

HQ region

North America

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others

Core offering

NTSAD is a nonprofit patient advocacy organization that supports individuals and families affected by Tay-Sachs, Canavan, GM1, and Sandhoff diseases through education, family services, and awareness efforts. It actively connects the patient community with emerging clinical trials and ongoing therapeutic research for these allied lysosomal storage disorders. The association also serves as an information hub and convener for the affected community, researchers, and clinicians working on treatments.

Differentiator

Problem solved

Functional benefit

Products and services

• Family Support and Patient Services

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves1 record

Direct peers

• National PKU Alliance: Advocacy organization for phenylketonuria, another rare inherited metabolic disease. Mirrors NTSAD's structure as a disease-focused family support and research foundation.
• Hunter Syndrome Foundation: Small disease-specific non-profit supporting research and families affected by a rare lysosomal storage disorder. Operates at a similar scale and focus to NTSAD.
• Cure SMA: Disease-specific non-profit funding spinal muscular atrophy research and supporting affected families. Closely parallels NTSAD's role for Tay-Sachs and allied diseases.
• MLD Foundation: Non-profit focused on metachromatic leukodystrophy, a rare lysosomal storage disease adjacent to the Tay-Sachs/GM1/Sandhoff cluster. Shares the rare-disease advocacy and trial-partner profile.
• Children's Tumor Foundation: Non-profit dedicated to neurofibromatosis research and family support. Comparable disease-specific advocacy/funding model targeting a rare genetic disorder cluster.

Broad incumbents

• EveryLife Foundation for Rare Diseases: Policy-focused rare disease non-profit. NTSAD and other disease-specific groups frequently coordinate with EveryLife on legislative and regulatory advocacy.
• Cystic Fibrosis Foundation: Large disease-specific non-profit that funds research and drug development for a single rare genetic disease. NTSAD mirrors this model for Tay-Sachs and allied diseases on a smaller scale.
• Global Genes: Alliance of rare disease patient organizations providing shared tools, education, and advocacy infrastructure. Operates as a peer support layer for groups like NTSAD.
• National Organization for Rare Disorders (NORD): Umbrella advocacy organization for all rare diseases in the US. NTSAD operates as a disease-specific member within the broader NORD ecosystem and competes for similar donor and policy attention.
• Muscular Dystrophy Association (MDA): Disease-focused non-profit that funds research, clinical care, and family services across a cluster of related neuromuscular diseases. Structurally similar to NTSAD's multi-disease platform approach.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks4 records

Key highlights5 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about National Tay-Sachs & Allied Diseases Association